The global biotech API manufacturing services market, valued at US$ 38.9 Bn in 2022, is anticipated to grow at a CAGR of 7.1% and exceed US$ 73 Bn by 2031. Factors such as increasing demand for ...

Ajinomoto OmniChem, an innovative provider of small molecule API, contract development and manufacturing services, today announced the successful completion of a commercial scale manufacturing ...